Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

CADENCE PHARMACEUTICALS INC (CADX)

Income Statement Business | Product

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09Dec-31-08Dec-31-07Dec-31-06
   10-K10-K10-K10-K10-K10-K10-K10-K
Total revenues   [+]112.650.216.70.00.040.041.847.8
            Revenue growth  124.3%200.6%  -100.0%-4.2%-12.6%-99.2%
Cost of goods sold  38.023.312.40.00.040.041.847.8
Gross profit  74.626.94.30.00.00.00.00.0
            Gross margin  66.3%53.7%25.7%  0.0%0.0%0.0%
Selling, general and administrative   [+]94.586.881.539.324.614.112.55.8
Research and development  6.76.58.913.819.5   
Other operating expenses  0.92.51.50.30.442.441.847.8
EBITDA   [+]-26.0-66.0-84.4-52.6-44.0-56.0-53.7-53.4
            EBITDA margin  -23.1%-131.6%-505.3%  -139.9%-128.6%-111.6%
Depreciation  0.21.61.70.80.50.50.50.2
EBITA  -26.2-67.6-86.0-53.4-44.5-56.5-54.2-53.6
            EBITA margin  -23.3%-134.7%-515.3%  -141.3%-129.8%-112.0%
Amortization of intangibles  1.31.31.6     
EBIT   [+]-27.5-69.0-87.6-53.4-44.5-56.5-54.2-53.6
            EBIT margin  -24.5%-137.4%-524.7%  -141.3%-129.8%-112.0%
Non-recurring items   [+] 7.71.11.5    
Interest expense, net   [+]4.44.34.32.01.00.4-2.5-1.4
Other income (expense), net  7.60.00.00.30.0-0.20.00.0
Pre-tax income  -24.3-81.0-93.0-56.6-45.5-57.1-51.7-52.2
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -24.3-81.0-93.0-56.6-45.5-57.1-51.7-52.2
            Net margin  -21.6%-161.4%-557.1%  -142.7%-123.8%-109.1%
   
Basic EPS   [+]($0.28)($0.95)($1.41)($1.09)($0.93)($1.55)($1.81)($10.07)
Diluted EPS   [+]($0.28)($0.95)($1.41)($1.09)($0.93)($1.55)($1.81)($10.07)
   
Shares outstanding (basic)   [+]86.085.666.152.048.836.828.65.2
Shares outstanding (diluted)   [+]86.085.666.152.048.836.828.65.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy